Research shows that worldwide in type 2 diabetic patients is still the prevailing high blood glucose levels, insulin therapy in the treatment of late starting, as well as diabetes is associated with a high complication rate problem.
Research shows that worldwide in type 2 diabetic patients is still the prevailing high blood glucose levels, insulin therapy in the treatment of late starting, as well as diabetes is associated with a high complication rate problem.
In patients with diabetes using insulin treatment, blood glucose control was generally poor, mean HbA1c level was 9.5%, significantly higher than the international academic circles generally approved of the 7% goal. Up to 75% of the acceptable test in diabetic patients with cardiovascular disease, more than 84% of the subjects associated with other diabetes related complications, including nephropathy, retinopathy, and neuropathy of the foot, and these complications are diabetic death, the main cause of handicap.
In the study, about 9% of the patients with diabetes mellitus mean HbA1c levels higher than 10%, but they had not taken any antidiabetic drugs. But only those taking oral antidiabetic therapy in patients, the duration of diabetes ranged from 5.9 years to 10.4 years, suggesting that these patients starting insulin therapy has obvious delay. In addition, the past has been used in patients treated with insulin insulin dosage is small, but not with the progression of the disease with increasing doses, it is not effective in controlling blood glucose is one of the main reasons.
No comments:
Post a Comment